Progyny (NASDAQ:PGNY – Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, August 6th. Analysts expect Progyny to post earnings of $0.36 per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link.
Progyny (NASDAQ:PGNY – Get Free Report) last announced its quarterly earnings results on Thursday, May 9th. The company reported $0.17 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.03. Progyny had a return on equity of 11.61% and a net margin of 5.53%. The company had revenue of $278.08 million during the quarter, compared to analysts’ expectations of $289.41 million. During the same period in the prior year, the company earned $0.18 EPS. Progyny’s revenue was up 7.6% compared to the same quarter last year. On average, analysts expect Progyny to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Progyny Stock Up 1.4 %
Progyny stock traded up $0.42 during trading hours on Tuesday, hitting $29.44. The stock had a trading volume of 91,538 shares, compared to its average volume of 947,006. The business’s 50 day simple moving average is $27.64 and its 200-day simple moving average is $32.92. Progyny has a one year low of $23.90 and a one year high of $44.95. The stock has a market cap of $2.80 billion, a price-to-earnings ratio of 47.57, a P/E/G ratio of 1.89 and a beta of 1.46.
Wall Street Analysts Forecast Growth
Read Our Latest Research Report on Progyny
Insider Activity at Progyny
In other news, President Michael E. Sturmer sold 4,515 shares of the business’s stock in a transaction that occurred on Wednesday, May 1st. The stock was sold at an average price of $31.95, for a total transaction of $144,254.25. Following the completion of the sale, the president now owns 380,038 shares in the company, valued at $12,142,214.10. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, President Michael E. Sturmer sold 4,515 shares of the stock in a transaction on Wednesday, May 1st. The stock was sold at an average price of $31.95, for a total value of $144,254.25. Following the transaction, the president now directly owns 380,038 shares in the company, valued at approximately $12,142,214.10. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, President Michael E. Sturmer sold 9,030 shares of the business’s stock in a transaction on Tuesday, July 16th. The shares were sold at an average price of $30.00, for a total transaction of $270,900.00. Following the sale, the president now owns 362,583 shares of the company’s stock, valued at approximately $10,877,490. The disclosure for this sale can be found here. Insiders sold 15,007 shares of company stock valued at $456,660 in the last three months. Corporate insiders own 12.30% of the company’s stock.
Progyny Company Profile
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Read More
- Five stocks we like better than Progyny
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Aerospace Stock Fires Up a Solid EPS Beat and Raises Guidance
- Top Biotech Stocks: Exploring Innovation Opportunities
- Pharma Stock Cuts Earnings Outlook: Still a Buying Opportunity
- How to Invest in the Best Canadian Stocks
- This Semiconductor Stock Is ON Track for a New High
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.